TNL Mediagene Ordinary Shares is a forward-thinking biopharmaceutical company dedicated to the development and commercialization of cutting-edge medical therapies aimed at addressing significant unmet medical needs, particularly in the fields of oncology and autoimmune disorders. With a robust pipeline leveraging advanced technologies and strategic partnerships, the company is well-positioned for substantial growth in the dynamic healthcare landscape. TNL Mediagene's unwavering commitment to scientific research and innovative approaches underpins its mission to improve patient outcomes,…